patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten

Exactly !!!! That's why I am here like you!

Share
New Message
Please login to post a reply